Cargando…

Latanoprost with high precision, piezo-print microdose delivery for IOP lowering: clinical results of the PG21 study of 0.4 µg daily microdose

BACKGROUND: Topical high-precision piezo-print delivery of microdoses of latanoprost achieved significant IOP reduction consistent with the eyedropper effect but with a 75% reduced exposure to drugs and preservatives. Prostaglandin analogs are a mainstay glaucoma therapy. However, conventional eyedr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasquale, Louis R, Lin, Shan, Weinreb, Robert N, Tsai, James C, Kramm, Robert L, Ianchulev, Tsontcho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276603/ https://www.ncbi.nlm.nih.gov/pubmed/30568423 http://dx.doi.org/10.2147/OPTH.S185027

Ejemplares similares

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010)

Asking questions of psychedelic microdosing
por: Cameron, Lindsay P
Publicado: (2021)

A systematic study of microdosing psychedelics
por: Polito, Vince, et al.
Publicado: (2019)

The therapeutic potential of microdosing psychedelics in depression
por: Kuypers, Kim P.C.
Publicado: (2020)

Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
por: Rootman, Joseph M., et al.
Publicado: (2021)

Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Phase 0 - Microdosing strategy in clinical trials
por: Rani, P. Usha, et al.
Publicado: (2008)

Psychedelic microdosing benefits and challenges: an empirical codebook
por: Anderson, Thomas, et al.
Publicado: (2019)

Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
por: Rootman, Joseph M., et al.
Publicado: (2022)

Motives and Side-Effects of Microdosing With Psychedelics Among Users
por: Hutten, Nadia R P W, et al.
Publicado: (2019)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

Buprenorphine Microdosing Cross Tapers: A Time for Change
por: Raheemullah, Amer, et al.
Publicado: (2022)

Disease Detection by Ultrasensitive Quantification of Microdosed Synthetic Urinary Biomarkers
por: Warren, Andrew D., et al.
Publicado: (2014)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

Microbial population dynamics under microdoses of the essential oil arborvitae
por: McGregor, Rhegan C., et al.
Publicado: (2019)

Powerful substances in tiny amounts: An interview study of psychedelic microdosing
por: Johnstad, Petter Grahl
Publicado: (2018)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Outpatient Microdose Induction with Transdermal Buprenorphine: A Case Series
por: Menard, Shannon, et al.
Publicado: (2022)

Experiences of microdosing psychedelics in an attempt to support wellbeing and mental health
por: Ryan, Rebecca S., et al.
Publicado: (2023)

Subjective and Objective Measurements of the Facial Effects of Microdoses of Botulinum Toxin
por: Hexsel, Doris, et al.
Publicado: (2023)

Exploring the effect of microdosing psychedelics on creativity in an open-label natural setting
por: Prochazkova, Luisa, et al.
Publicado: (2018)

Dose‐linearity of the pharmacokinetics of an intravenous [(14)C]midazolam microdose in children
por: van Groen, Bianca D., et al.
Publicado: (2019)

Intratarget Microdosing for Deep Phenotyping of Multiple Drug Effects in the Live Brain
por: Kim, Jennifer, et al.
Publicado: (2022)

Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
por: Cavanna, Federico, et al.
Publicado: (2022)

Ibogaine microdosing in a patient with bipolar depression: a case report
por: Fernandes-Nascimento, Maria Helha, et al.
Publicado: (2022)

Oral bioavailability of microdoses and therapeutic doses of midazolam as a 2-dimensionally printed orodispersible film in healthy volunteers
por: Breithaupt, Mareile H., et al.
Publicado: (2022)

Automated Microdosing System for Integration With a Miniaturized High-pressure Reactor System
por: Stoll, Norbert, et al.
Publicado: (2005)

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development
por: Burt, T, et al.
Publicado: (2016)

Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
por: Kuypers, Kim PC, et al.
Publicado: (2019)

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
por: Kaertner, L. S., et al.
Publicado: (2021)

The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
por: Kinderlehrer, Daniel A
Publicado: (2023)

Use of microdoses for induction of buprenorphine treatment with overlapping full opioid agonist use: the Bernese method
por: Hämmig, Robert, et al.
Publicado: (2016)

Successful Use of [(14)C]Paracetamol Microdosing to Elucidate Developmental Changes in Drug Metabolism
por: Mooij, Miriam G., et al.
Publicado: (2017)

Evaluation of CYP2C19 activity using microdosed oral omeprazole in humans
por: Elbe, Annika, et al.
Publicado: (2022)

Factors that distinguish opioid withdrawal during induction with buprenorphine microdosing: a configurational analysis
por: K. K., Adams, et al.
Publicado: (2022)

Microdosing Sprint Distribution as an Alternative to Achieve Better Sprint Performance in Field Hockey Players
por: Cuadrado-Peñafiel, Víctor, et al.
Publicado: (2023)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023)

The effects of microdose LSD on time perception: a randomised, double-blind, placebo-controlled trial
por: Yanakieva, Steliana, et al.
Publicado: (2018)

Microdose lithium reduces cellular senescence in human astrocytes - a potential pharmacotherapy for COVID-19?
por: Viel, Tania, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c1929psqejki35fc4j3etg82cb